Dr. Ravi Majeti: Transforming the detection of minimal residual disease (MRD) with single-cell DNA analysis

RESEARCHER SPOTLIGHT

Dr. Ravi Majeti shares his thoughts on using the Tapestriā„¢ Platform to measure residual disease in acute
myeloid leukemia (AML)